18 New method of assessing tumor heterogeneity utilizing both circulating tumor DNA and tissue DNA to predict the response to immunotherapy

• Young Kwang Chae,
• Jaeyoun Choi,
• Myungwoo Nam,
• Stanislav Fridland,
• Jinyoung Hwang,
• Chan Mi Jung,
• Christmann Low

Affiliations

Young Kwang Chae

Aff1 Developmental Therapeutics Program of the Division of Hematology Oncology, Early Phase Clinical Trials Unit 645 N. Michigan Avenue, Suite 1006 60611 Chicago IL USA

Jaeyoun Choi

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Myungwoo Nam

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Stanislav Fridland

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Jinyoung Hwang

1Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Chan Mi Jung

2Northwestern University Weinberg School of Arts and Sciences, Chicago, IL, USA

Christmann Low

2Northwestern University Weinberg School of Arts and Sciences, Chicago, IL, USA